OSSIUM INVENTA
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97311081
- Registration number
- 7706863
- Mark type
- Stylized text
- Filed
- 14 Mar 2022
- Published for opposition
- 18 Apr 2023
- Registered
- 25 Feb 2025
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 001 — Chemicals: Biological tissues, namely, bone marrow, stem cells, and blood, all for use in scientific and medical research; cells for scientific, laboratory and medical research
- Class 005 — Pharmaceuticals: Biological tissues, namely, bone marrow, stem cells, and blood, all for use in medical therapy use; cells for medical therapy use
- Class 040 — Treatment of materials: Bone marrow processing for transport
- Class 042 — Scientific and technological services: Biological, technical and scientific research in the fields of oncology, immunology and organ and limb transplantation, wound healing, and radiation treatment
- Class 044 — Medical, beauty and agricultural services: Medical testing of bone marrow; tissue bank services in the nature of collection and preservation of human bone marrow; cultured cell bank services for medical transplantation
Owner
- Ossium Health, Inc., San Francisco, CA, US
- Ossium Health, Inc., San Francisco, CA, US
- Ossium Health, Inc., San Francisco, CA, US
Prosecution history
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Dec 2024 — ASSIGNED TO LIE
- 17 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jul 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Jul 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 03 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 May 2024 — NON-FINAL ACTION E-MAILED
- 03 May 2024 — SU - NON-FINAL ACTION - WRITTEN
- 11 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Dec 2023 — USE AMENDMENT FILED